id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-320548-oigyut2k	Zumla, Alimuddin	Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options	2014-09-01		.txt	text/plain	8128	249	22	A antibodies Antiviral combinations for severe infl uenza infections: a review Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant infl uenza virus strains in vitro Effi cacy of oseltamivirzanamivir combination compared to each monotherapy for seasonal infl uenza: a randomized placebo-controlled trial Triple-combination antiviral drug for pandemic H1N1 infl uenza virus infection in critically ill patients on mechanical ventilation Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure Anti-malaria drug chloroquine is highly eff ective in treating avian infl uenza A H5N1 virus infection in an animal model Eff ectiveness of chloroquine against infl uenza Chloroquine for infl uenza prevention: a randomised, double-blind, placebo controlled trial International Severe Acute Respiratory and Emerging Infections Consortium Treatment of MERS-CoV: information for clinicians. Romark announces clinical trial results for new infl uenza drug presented at IDSA meeting Eff ect of nitazoxanide in adults and adolescents with acute uncomplicated infl uenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial Adjunctive therapies and immunomodulatory agents in the management of severe infl uenza The eff ectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral aetiology: a systematic review and exploratory meta-analysis Convalescent plasma treatment reduced mortality in patients with severe pandemic infl uenza A (H1N1) 2009 virus infection Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 infl uenza A(H1N1) infection An in vivo human-plasmablast enrichment technique allows rapid identifi cation of therapeutic infl uenza	cache/cord-320548-oigyut2k.txt	txt/cord-320548-oigyut2k.txt
